Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

How saturated fats may be a causative factor in multiple sclerosis and other diseases.

Swank RL, Goodwin JW.

Nutrition. 2003 May;19(5):478. No abstract available.

PMID:
12714108
2.

Review of MS patient survival on a Swank low saturated fat diet.

Swank RL, Goodwin J.

Nutrition. 2003 Feb;19(2):161-2. Review. No abstract available.

PMID:
12591551
3.

Microfiltration and microemboli: a history.

Swank RL, Seaman GV.

Transfusion. 2000 Jan;40(1):114-9. Review. No abstract available.

PMID:
10644821
4.
5.

Pyloric stenosis.

Swank RL 2nd.

Pediatr Ann. 1994 Jul;23(7):328. No abstract available.

PMID:
7970894
6.

Multiple sclerosis: fat-oil relationship.

Swank RL.

Nutrition. 1991 Sep-Oct;7(5):368-76.

PMID:
1804476
7.

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

Swank RL, Dugan BB.

Lancet. 1990 Jul 7;336(8706):37-9.

PMID:
1973220
8.

Multiple sclerosis: the lipid relationship.

Swank RL, Grimsgaard A.

Am J Clin Nutr. 1988 Dec;48(6):1387-93.

PMID:
3202088
9.

Polystyrene latex particles as indicators of abnormal plasma properties in multiple sclerosis.

Seaman GV, Swank RL, Tamblyn CH.

Neurology. 1984 Apr;34(4):547-9.

PMID:
6538317
10.

Changes in postural control and vision induced by multiple sclerosis.

Daley ML, Swank RL.

Agressologie. 1983 Jun;24(7):327-9. No abstract available.

PMID:
6638322
11.

Cerebral blood flow and red cell delivery in normal subjects and in multiple sclerosis.

Swank RL, Roth JG, Woody DC Jr.

Neurol Res. 1983;5(1):37-59.

PMID:
6140655
12.

Quantitative posturography: use in multiple sclerosis.

Daley ML, Swank RL.

IEEE Trans Biomed Eng. 1981 Sep;28(9):668-71. No abstract available.

PMID:
7319527
13.

Plasma origin of red-cell-membrane changes in multiple sclerosis.

Seaman GV, Swank RL, Tamblyn CH.

Lancet. 1980 Apr 26;1(8174):938. No abstract available.

PMID:
6103296
14.

Platelet count ratio (PCR) as an additional parameter in the quantitation of platelet aggregation in vitro.

Benner KU, Tamblyn CH, Swank RL, Seaman GV.

Thromb Res. 1980 Mar 15;17(6):801-8. No abstract available.

PMID:
7404488
15.

Red cell electrophoretic mobility test for early diagnosis of multiple sclerosis.

Tamblyn CH, Swank RL, Seaman GV, Zukoski CF 4th.

Neurol Res. 1980;2(1):69-83.

PMID:
6114451
16.

Myelin basic protein binding cells in active multiple sclerosis.

Vandenbark AA, Hallum JV, Swank RL, Tong A, Burger DR.

Ann Neurol. 1979 Jul;6(1):8-12.

PMID:
92212
17.

Red-cell-membrane differences in multiple sclerosis are acquired from plasma.

Seaman GV, Swank RL, Zukoski CF 4th.

Lancet. 1979 May 26;1(8126):1139. No abstract available.

PMID:
86857
18.

Simplified red-cell electrophoretic mobility test for multiple sclerosis.

Seaman GV, Swank RL, Tamblyn CH, Zukoski CF 4th.

Lancet. 1979 May 26;1(8126):1138-9. No abstract available.

PMID:
86856
19.

Flicker fusion thresholds in multiple sclerosis. A functional measure of neurological damage.

Daley ML, Swank RL, Ellison CM.

Arch Neurol. 1979 May;36(5):292-5.

PMID:
444097
20.

Comparison of methods for the evaluation of microaggregate removal by blood transfusion filters.

Tamblyn CH, Nordt FJ, Swank RL, Zukoski CF 4th, Seaman GV.

Biorheology. 1979;16(4-5):339-46. No abstract available.

PMID:
534756

Supplemental Content

Loading ...
Support Center